Guru Ownership Trend
Guru Analysis for Tyra Biosciences, Inc. (TYRA)
Tyra Biosciences, Inc. (TYRA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $36.9 M.
Top institutional holders include Steven Cohen and Ken Fisher.
Institutional sentiment is currently Bullish. This is evidenced by a $13.81 M net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 210.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Tyra Biosciences, Inc. (TYRA)
Major holders include Steven Cohen ($22.98 M), Ken Fisher ($757,152), Cliff Asness ($752,707). According to the latest reported data, 3 tracked investment managers collectively hold approximately 931,623 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $13.81 M, with 3 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 2 fully exited TYRA. The total reported sell value was $2.53 M.
Yes, 1 managers opened new positions in TYRA, and 2 increased their existing holdings. The total reported buy value was $16.34 M.